(Q38829534)

English

Urolithins, the rescue of "old" metabolites to understand a "new" concept: Metabotypes as a nexus among phenolic metabolism, microbiota dysbiosis, and host health status

scientific article published on 9 May 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 September 2017

1 reference

Europe PubMed Central

Urolithins, the rescue of "old" metabolites to understand a "new" concept: Metabotypes as a nexus among phenolic metabolism, microbiota dysbiosis, and host health status (English)

1 reference

Europe PubMed Central

6 September 2017

1 reference

based on heuristic

inferred from title

Juan Carlos Espín

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27158799%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Francisco A Tomas-Barberan

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27158799%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Antonio González-Sarrías

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27158799%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Rocio Garcia Villalba

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27158799%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

María A Nuñez-Sánchez

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27158799%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

María Victoria Selma

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27158799%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

María-Teresa García-Conesa

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27158799%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

author name string

Francisco A Tomás-Barberán

1

1 reference

Europe PubMed Central

6 September 2017

Antonio González-Sarrías

2

1 reference

Europe PubMed Central

6 September 2017

Rocío García-Villalba

3

1 reference

Europe PubMed Central

6 September 2017

María A Núñez-Sánchez

4

1 reference

Europe PubMed Central

6 September 2017

María V Selma

5

1 reference

Europe PubMed Central

6 September 2017

María T García-Conesa

6

1 reference

Europe PubMed Central

6 September 2017

publication date

9 May 2016

1 reference

Europe PubMed Central

6 September 2017

Molecular Nutrition and Food Research

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27158799%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

61

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27158799%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27158799%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Ellagitannins, ellagic acid and vascular health.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Metabolic fate of ellagitannins: implications for health, and research perspectives for innovative functional foods

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

UV and MS identification of Urolithins and Nasutins, the bioavailable metabolites of ellagitannins and ellagic acid in different mammals.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Isolation of two benzocoumarins from 'clover stone' a type of renal calculus found in sheep

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Natural dibenzo-α-pyrones and their bioactivities.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Evaluation of the bioavailability and metabolism in the rat of punicalagin, an antioxidant polyphenol from pomegranate juice

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Metabolism of antioxidant and chemopreventive ellagitannins from strawberries, raspberries, walnuts, and oak-aged wine in humans: identification of biomarkers and individual variability

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Biological significance of urolithins, the gut microbial ellagic Acid-derived metabolites: the evidence so far

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

New insights into the bioavailability of red raspberry anthocyanins and ellagitannins.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Pomegranate juice supplementation in chronic obstructive pulmonary disease: a 5-week randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Soy protein isolate does not affect ellagitannin bioavailability and urolithin formation when mixed with pomegranate juice in humans.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Pomegranate extract induces ellagitannin metabolite formation and changes stool microbiota in healthy volunteers

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Pomegranate juice and extracts provide similar levels of plasma and urinary ellagitannin metabolites in human subjects

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Effect of daily intake of pomegranate juice on fecal microbiota and feces metabolites from healthy volunteers.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Bioavailability of anthocyanins and ellagitannins following consumption of raspberries by healthy humans and subjects with an ileostomy.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Iberian pig as a model to clarify obscure points in the bioavailability and metabolism of ellagitannins in humans.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Identification of urolithin a as a metabolite produced by human colon microflora from ellagic acid and related compounds

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Time course production of urolithins from ellagic acid by human gut microbiota.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate gland

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Absorption, metabolism, and effects at transcriptome level of a standardized French oak wood extract, Robuvit, in healthy volunteers: pilot study.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Colonic catabolism of ellagitannins, ellagic acid, and raspberry anthocyanins: in vivo and in vitro studies.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Safety evaluation of an oak-flavored milk powder containing ellagitannins upon oral administration in the rat.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Strawberry processing does not affect the production and urinary excretion of urolithins, ellagic acid metabolites, in humans.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Identification of urinary and intestinal bacterial metabolites of ellagitannin geraniin in rats.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Effect of a walnut meal on postprandial oxidative stress and antioxidants in healthy individuals

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

A double-blind, randomized, neoadjuvant study of the tissue effects of POMx pills in men with prostate cancer before radical prostatectomy

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Intestinal bacterium Eubacterium cellulosolvens deglycosylates flavonoid C- and O-glucosides

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Interaction between phenolics and gut microbiota: role in human health.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Description of urolithin production capacity from ellagic acid of two human intestinal Gordonibacter species

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Gordonibacter urolithinfaciens sp. nov., a urolithin-producing bacterium isolated from the human gut.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Enantioselective synthesis of S-equol from dihydrodaidzein by a newly isolated anaerobic human intestinal bacterium

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Slackia equolifaciens sp. nov., a human intestinal bacterium capable of producing equol

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Isolation of a human intestinal bacterium capable of daidzein and genistein conversion

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Intestinal bacterial communities that produce active estrogen-like compounds enterodiol and enterolactone in humans

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

In vitro transformation of chlorogenic acid by human gut microbiota

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

In vivo and in vitro metabolism of trans-resveratrol by human gut microbiota.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Adlercreutzia equolifaciens gen. nov., sp. nov., an equol-producing bacterium isolated from human faeces, and emended description of the genus Eggerthella

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

In vitro antiproliferative and antioxidant effects of urolithin A, the colonic metabolite of ellagic acid, on hepatocellular carcinomas HepG2 cells

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

A survey of modulation of gut microbiota by dietary polyphenols.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

The influence of pomegranate by-product and punicalagins on selected groups of human intestinal microbiota

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Validated Method for the Characterization and Quantification of Extractable and Nonextractable Ellagitannins after Acid Hydrolysis in Pomegranate Fruits, Juices, and Extracts.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Urolithins, ellagitannin metabolites produced by colon microbiota, inhibit Quorum Sensing in Yersinia enterocolitica: Phenotypic response and associated molecular changes.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Enterotypes of the human gut microbiome

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Talking microbes: When gut bacteria interact with diet and host organs

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Occurrence of urolithins, gut microbiota ellagic acid metabolites and proliferation markers expression response in the human prostate gland upon consumption of walnuts and pomegranate juice.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Effects of ellagitannin-rich berries on blood lipids, gut microbiota, and urolithin production in human subjects with symptoms of metabolic syndrome

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

The human gut microbial ecology associated with overweight and obesity determines ellagic acid metabolism

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Plasma metabolomic biomarkers of mixed nuts exposure inversely correlate with severity of metabolic syndrome

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Pomegranate juice augments memory and FMRI activity in middle-aged and older adults with mild memory complaints.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Fate of microbial metabolites of dietary polyphenols in rats: is the brain their target destination?

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Nutraceuticals: facts and fiction

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

The ellagitannin colonic metabolite urolithin D selectively inhibits EphA2 phosphorylation in prostate cancer cells.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Antiatherogenic effects of ellagic acid and urolithins in vitro

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Comprehensive characterization of the effects of ellagic acid and urolithins on colorectal cancer and key-associated molecular hallmarks: MicroRNA cell specific induction of CDKN1A (p21) as a common mechanism involved.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Phase-II metabolism limits the antiproliferative activity of urolithins in human colon cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Chemopreventive activity of ellagitannins and their derivatives from black raspberry seeds on HT-29 colon cancer cells.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Urolithin A causes p21 up-regulation in prostate cancer cells.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Dissimilar in vitro and in vivo effects of ellagic acid and its microbiota-derived metabolites, urolithins, on the cytochrome P450 1A1.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Influence of gut microbiota-derived ellagitannins' metabolites urolithins on pro-inflammatory activities of human neutrophils.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Role of human gut microbiota metabolism in the anti-inflammatory effect of traditionally used ellagitannin-rich plant materials

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

NF-kappaB-dependent anti-inflammatory activity of urolithins, gut microbiota ellagic acid-derived metabolites, in human colonic fibroblasts.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Intestinal ellagitannin metabolites ameliorate cytokine-induced inflammation and associated molecular markers in human colon fibroblasts.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Urolithins, intestinal microbial metabolites of Pomegranate ellagitannins, exhibit potent antioxidant activity in a cell-based assay

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

In vitro antioxidant and antiproliferative effects of ellagic acid and its colonic metabolite, urolithins, on human bladder cancer T24 cells.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

In Vitro Bioaccessibility, Human Gut Microbiota Metabolites and Hepatoprotective Potential of Chebulic Ellagitannins: A Case of Padma Hepaten® Formulation

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Metabolites of the ellagitannin geraniin and their antioxidant activities

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Pomegranate: a fruit that ameliorates metabolic syndrome

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Urolithin A, C, and D, but not iso-urolithin A and urolithin B, attenuate triglyceride accumulation in human cultures of adipocytes and hepatocytes.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Modelling the possible bioactivity of ellagitannin-derived metabolites. In silico tools to evaluate their potential xenoestrogenic behavior

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Antiglycative and neuroprotective activity of colon-derived polyphenol catabolites

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Ellagitannin oligomers and a neolignan from pomegranate arils and their inhibitory effects on the formation of advanced glycation end products

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Pomegranate phenolics inhibit formation of advanced glycation endproducts by scavenging reactive carbonyl species

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Pomegranate's Neuroprotective Effects against Alzheimer's Disease Are Mediated by Urolithins, Its Ellagitannin-Gut Microbial Derived Metabolites.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Pomegranate from Oman Alleviates the Brain Oxidative Damage in Transgenic Mouse Model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Long-term (15 mo) dietary supplementation with pomegranates from Oman attenuates cognitive and behavioral deficits in a transgenic mice model of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Ellagitannins of the fruit rind of pomegranate (Punica granatum) antagonize in vitro the host inflammatory response mechanisms involved in the onset of malaria

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Ellagic Acid and Polyhydroxylated Urolithins Are Potent Catalytic Inhibitors of Human Topoisomerase II: An in Vitro Study

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

MicroRNAs expression in normal and malignant colon tissues as biomarkers of colorectal cancer and in response to pomegranate extracts consumption: Critical issues to discern between modulatory effects and potential artefacts.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Food Polyphenols Fail to Cause a Biologically Relevant Reduction of COX-2 Activity

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

High concordance of daidzein-metabolizing phenotypes in individuals measured 1 to 3 years apart.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Obesity prevalence in relation to gut microbial environments capable of producing equol or O-desmethylangolensin from the isoflavone daidzein.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Daidzein-metabolizing phenotypes in relation to bone density and body composition among premenopausal women in the United States.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Acute benefits of the microbial-derived isoflavone metabolite equol on arterial stiffness in men prospectively recruited according to equol producer phenotype: a double-blind randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Vasorelaxant and antioxidant activity of the isoflavone metabolite equol in carotid and cerebral arteries.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Concentrated pomegranate juice improves lipid profiles in diabetic patients with hyperlipidemia

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Repeated oral administration of high doses of the pomegranate ellagitannin punicalagin to rats for 37 days is not toxic

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Development of a targeted method for twenty-three metabolites related to polyphenol gut microbial metabolism in biological samples, using SPE and UHPLC-ESI-MS/MS.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Structural elucidation and quantification of phenolic conjugates present in human urine after tea intake.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Absorption, metabolism, and antioxidant effects of pomegranate (Punica granatum l.) polyphenols after ingestion of a standardized extract in healthy human volunteers.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Gene expression, cell cycle arrest and MAPK signalling regulation in Caco-2 cells exposed to ellagic acid and its metabolites, urolithins.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Antiproliferative activity of the ellagic acid-derived gut microbiota isourolithin A and comparison with its urolithin A isomer: the role of cell metabolism.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

The ellagic acid-derived gut microbiota metabolite, urolithin A, potentiates the anticancer effects of 5-fluorouracil chemotherapy on human colon cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Colon cancer chemopreventive activities of pomegranate ellagitannins and urolithins

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

The ellagic acid derivative 4,4'-di-O-methylellagic acid efficiently inhibits colon cancer cell growth through a mechanism involving WNT16.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Effects of fruit ellagitannin extracts, ellagic acid, and their colonic metabolite, urolithin A, on Wnt signaling

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

The gut microbiota ellagic acid-derived metabolite urolithin A and its sulfate conjugate are substrates for the drug efflux transporter breast cancer resistance protein (ABCG2/BCRP).

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Effects of pomegranate chemical constituents/intestinal microbial metabolites on CYP1B1 in 22Rv1 prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Extracts from Epilobium sp. herbs, their components and gut microbiota metabolites of Epilobium ellagitannins, urolithins, inhibit hormone-dependent prostate cancer cells-(LNCaP) proliferation and PSA secretion.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Walnut polyphenol metabolites, urolithins A and B, inhibit the expression of the prostate-specific antigen and the androgen receptor in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Pomegranate Juice Metabolites, Ellagic Acid and Urolithin A, Synergistically Inhibit Androgen-Independent Prostate Cancer Cell Growth via Distinct Effects on Cell Cycle Control and Apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Urolithins display both antioxidant and pro-oxidant activities depending on assay system and conditions

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Pomegranate ellagitannin-derived compounds exhibit antiproliferative and antiaromatase activity in breast cancer cells in vitro

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Urolithin as a converging scaffold linking ellagic acid and coumarin analogues: design of potent protein kinase CK2 inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Urolithins, gut microbiota-derived metabolites of ellagitannins, inhibit LPS-induced inflammation in RAW 264.7 murine macrophages

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Antiplasmodial activity of Punica granatum L. fruit rind

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Inhibitory effect of ellagitannin metabolites on IgE-mediated allergic responses in RBL-2H3 cells

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Targeted metabolic profiling of pomegranate polyphenols and urolithins in plasma, urine and colon tissues from colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Urolithins Are the Main Urinary Microbial-Derived Phenolic Metabolites Discriminating a Moderate Consumption of Nuts in Free-Living Subjects with Diagnosed Metabolic Syndrome

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Chromatographic and spectroscopic characterization of urolithins for their determination in biological samples after the intake of foods containing ellagitannins and ellagic acid

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Ellagic Acid Metabolism by Human Gut Microbiota: Consistent Observation of Three Urolithin Phenotypes in Intervention Trials, Independent of Food Source, Age, and Health Status

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Metabolism of Oak Leaf Ellagitannins and Urolithin Production in Beef Cattle

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Ellagitannin metabolites, urolithin A glucuronide and its aglycone urolithin A, ameliorate TNF-α-induced inflammation and associated molecular markers in human aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Urolithins at physiological concentrations affect the levels of pro-inflammatory cytokines and growth factor in cultured cardiac cells in hyperglucidic conditions

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Identifying the limits for ellagic acid bioavailability: A crossover pharmacokinetic study in healthy volunteers after consumption of pomegranate extracts

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Interindividual variability in the human metabolism of ellagic acid: Contribution of Gordonibacter to urolithin production

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500901

21 January 2018

Identifiers

10.1002/MNFR.201500901

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27158799%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27158799%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38829534&oldid=2043300137"